EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Role of STING Deficiency in Amelioration of Mouse Models of Lupus and Atherosclerosis

Yudong Liu, Carmelo Carmona-Rivera iD, Nickie L Seto, Christopher B Oliveira, Eduardo Patino-Martinez, Yvonne Baumer, Tiffany M Powell-Wiley, Nehal Mehta, Sarfaraz Hasni, Xuan Zhang iD, Mariana J Kaplan

Arthritis & Rheumatology · 2025-05 · 77 (5) · 547-559

DOI: 10.1002/art.43062 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Arthritis & Rheumatology, online erschienen am 19.12.2024. Verfasst von Yudong Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Center for Clinical Laboratories, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital/National Center of …. Hauptthemen laut MEDLINE: Lupus Erythematosus, Systemic, Membrane Proteins, Atherosclerosis. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAMS NIH HHS, NHLBI NIH HHS, NIMHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Systemic lupus erythematosus (SLE) is a systemic autoimmune syndrome characterized by autoreactive responses to nucleic acids, dysregulation of the type I interferon (IFN‐I) pathway, and accelerated atherosclerosis. The stimulator of IFN genes (STING), a cytosolic DNA sensor, has pathogenic implications in various inflammatory diseases. However, its specific role in SLE pathogenesis, particularly in tissue damage, remains unclear. This study aimed to elucidate the role of STING in murine models of Toll‐like receptor 7 (TLR7)–driven lupus and atherosclerosis.

Methods

A TLR7‐driven lupus model was induced using imiquimod (IMQ) in wild‐type (WT) and STING knockout (Sting1 −/− ) mice on a B6 background. Mice were assessed for organ involvement, serum autoantibodies, and innate and adaptive immune responses. Additionally, Sting1 −/− mice were backcrossed to apolipoprotein E knockout (Apoe −/− ) mice, and both Apoe −/− and Apoe −/− Sting1 −/− mice were fed a high‐fat chow diet to induce atherosclerosis. Phenotypic assessments were conducted.

Results

Compared with IMQ‐treated WT mice, Sting1 −/− mice exhibited reduced disease severity in the lupus‐like phenotype, characterized by decreased splenomegaly, lower renal immune complex deposition and renal damage, diminished expansion of myeloid cells, and reduced activation of T and B lymphocytes. IMQ‐induced DNA release associated with IFN‐β production and subsequent IFN‐induced responses were attenuated in Sting1 −/− mice. DNase I treatment mitigated IMQ‐induced proinflammatory responses in WT mice but had no effect in Sting1 −/− mice. Furthermore, STING deficiency conferred protection against vascular damage and reduced atherosclerosis burden, accompanied by decreased IFN‐I production. Human monocyte–derived macrophages treated with IFN‐I significantly internalized more acetylated low‐density lipoprotein when compared with untreated cells, whereas an association between oxidized nucleic acids and disease activity and vascular damage was found in human SLE.

Conclusion

These findings highlight a pathogenic role of STING and downstream IFN responses in TLR7‐driven autoimmunity, vascular damage and atherosclerosis, supporting a therapeutic potential for STING inhibition in SLE treatment. Further research is warranted to elucidate the mechanisms underlying STING's involvement in these processes and to explore the feasibility of targeting STING as a therapeutic strategy in SLE and related autoimmune disorders. image

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lupus Erythematosus, SystemicMembrane ProteinsAtherosclerosisAnimalsMiceDisease Models, AnimalMice, KnockoutImiquimodToll-Like Receptor 7AutoantibodiesAdaptive ImmunityImmunity, InnateMembrane GlycoproteinsSTING Protein

Substanzen

Membrane ProteinsImiquimodToll-Like Receptor 7AutoantibodiesMembrane GlycoproteinsSting1 protein, mouseSTING ProteinTlr7 protein, mouse

Autor:innen und Institutionen

  • National Center for Clinical Laboratories, Institute of Geriatric Medicine, Chinese Academy of Medical Sciences, Beijing Hospital/National Center of Gerontology, Beijing, China, and National Institute of Arthritis and M…
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases, NIH, Bethesda, Maryland.
  • National Heart Lung and Blood Institute, NIH, Bethesda, Maryland.
  • National Heart Lung and Blood Institute, NIH and National Institute on Minority Health and Health Disparities, NIH, Bethesda, Maryland.
  • Beijing Hospital, National Center of Gerontology, Institute of Geriatric Medicine, Clinical Immunology Center, Graduate School of Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

ORCID-Profile: Carmelo Carmona-Rivera, Xuan Zhang

Förderung

  • NIAMS NIH HHS
  • NHLBI NIH HHS
  • NIMHD NIH HHS
  • National Natural Science Foundation of China
  • National Institute of Arthritis and Musculoskeletal and Skin Diseases
  • National Heart, Lung, and Blood Institute
  • National Institute on Minority Health and Health Disparities

Zitieren

APA

Liu, Y., Carmona-Rivera, C., Seto, N. L., Oliveira, C. B., Patino-Martinez, E., Baumer, Y., Powell-Wiley, T. M., Mehta, N., Hasni, S., Zhang, X., & Kaplan, M. J. (2025). Role of STING Deficiency in Amelioration of Mouse Models of Lupus and Atherosclerosis. Arthritis & Rheumatology, 77(5), 547-559. https://doi.org/10.1002/art.43062

Vancouver

Liu Y, Carmona-Rivera C, Seto NL, Oliveira CB, Patino-Martinez E, Baumer Y, et al. Role of STING Deficiency in Amelioration of Mouse Models of Lupus and Atherosclerosis. Arthritis & Rheumatology. 2025;77(5):547-559. doi:10.1002/art.43062

BibTeX
@article{Liu2025,
  author = {Liu, Yudong and Carmona-Rivera, Carmelo and Seto, Nickie L and Oliveira, Christopher B and Patino-Martinez, Eduardo and Baumer, Yvonne and Powell-Wiley, Tiffany M and Mehta, Nehal and Hasni, Sarfaraz and Zhang, Xuan and Kaplan, Mariana J},
  title = {Role of STING Deficiency in Amelioration of Mouse Models of Lupus and Atherosclerosis},
  journal = {Arthritis & Rheumatology},
  year = {2025},
  volume = {77},
  number = {5},
  pages = {547--559},
  doi = {10.1002/art.43062}
}
Kostenlos starten →